ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,704Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 262

$520K Total Retail Price of All Prescriptions

Rank: 18 out of 262

471 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 10,313 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
FUROSEMIDE 625 567 1 4
SIMVASTATIN 622 568 2 1
OMEPRAZOLE 519 460 3 5
AMLODIPINE BESYLATE 484 463 4 6
LEVOTHYROXINE SODIUM 421 396 5 2
LISINOPRIL 415 378 6 3
METOPROLOL TARTRATE 383 368 7 8
POTASSIUM CHLORIDE 338 294 8 10
METOPROLOL SUCCINATE 267 265 9 11
MELOXICAM 246 215 10 54
DONEPEZIL HCL 240 227 11 23
CITALOPRAM HBR 229 199 12 20
METFORMIN HCL 218 207 13 9
GABAPENTIN 207 160 14 19
WARFARIN SODIUM 192 164 15 12
HYDROCHLOROTHIAZIDE 183 169 16 7
DIGOXIN 171 159 17 28
SERTRALINE HCL 165 160 18 14
TRAMADOL HCL 141 93 19 18
CLOPIDOGREL 135 134 20 38
ATENOLOL 124 118 21 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 120 94 22 93
TAMSULOSIN HCL 112 97 23 25
PLAVIX 107 105 24 64
CARVEDILOL 102 78 25 31
ALENDRONATE SODIUM 101 101 26 21
CYMBALTA 92 65 27 67
NAMENDA 89 89 28 37
LOSARTAN POTASSIUM 89 89 28 17
ZOLPIDEM TARTRATE 88 75 30 26
ALLOPURINOL 87 81 31 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 85 32 24
SPIRONOLACTONE 83 65 33 58
DETROL LA 78 78 34 76
ATORVASTATIN CALCIUM 77 64 35 13
LACTULOSE 72 71 36 131
ADVAIR DISKUS 71 51 37 34
HYDROCODONE-ACETAMINOPHEN 71 62 S3 37 15
TRAZODONE HCL 71 51 37 36
GLIPIZIDE ER 71 65 37 143
DILTIAZEM ER 68 68 41 75
NAPROXEN 66 61 42 122
OXYBUTYNIN CHLORIDE 61 55 43 90
SINGULAIR 59 58 44 128
QUETIAPINE FUMARATE 59 24 44 71
CARBIDOPA-LEVODOPA 57 57 46 66
DOXYCYCLINE HYCLATE 57 41 46 119
PROAIR HFA 55 30 48 53
VERAPAMIL ER 55 55 48 94
AMITRIPTYLINE HCL 54 54 R 50 68
BENAZEPRIL HCL 53 53 51 99
LATANOPROST 52 52 52 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.